Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance

Research output: Contribution to journal › Comment/debate

Access to Document

@article{50765ea4759c4d409f968ba55e5c16c5,

title = "Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance",

author = "Sangeetha Venugopal and John Mascarenhas",

year = "2022",

month = jul,

doi = "10.1016/S2352-3026(22)00139-9",

language = "English",

volume = "9",

pages = "e462--e463",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "7",

}

TY - JOUR

T1 - Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance

AU - Venugopal, Sangeetha

AU - Mascarenhas, John

PY - 2022/7

Y1 - 2022/7

UR - https://www.scopus.com/pages/publications/85133584562

U2 - 10.1016/S2352-3026(22)00139-9

DO - 10.1016/S2352-3026(22)00139-9

M3 - Comment/debate

C2 - 35597253

AN - SCOPUS:85133584562

SN - 2352-3026

VL - 9

SP - e462-e463

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 7

ER -